Synbio International Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2007	FY 2006	FY 2005	FY 2004
Period Ending	Dec '23 Dec 31, 2023	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004
Revenue	-	0.1	0.11	0.11	-
Revenue Growth (YoY)	-	-14.26%	0.81%	-	-
Cost of Revenue	-	0.08	0.09	0.09	-
Gross Profit	-	0.01	0.02	0.03	-
Selling, General & Admin	0.47	0.45	0.56	0.24	0.21
Operating Expenses	0.47	0.45	0.56	0.24	0.21
Operating Income	-0.47	-0.43	-0.54	-0.21	-0.21
Other Non Operating Income (Expenses)	-	-	-	0	-
Pretax Income	-0.47	-0.43	-0.54	-0.21	-0.21
Net Income	-0.47	-0.43	-0.54	-0.21	-0.21
Net Income to Common	-0.47	-0.43	-0.54	-0.21	-0.21
Shares Outstanding (Basic)	386	137	97	57	51
Shares Outstanding (Diluted)	386	137	97	57	51
Shares Change (YoY)	182.52%	40.98%	68.96%	11.68%	-
EPS (Basic)	-0.00	-0.00	-0.01	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.01	-0.00	-0.00
Free Cash Flow	-0.11	-0.31	-0.36	-0.1	-1
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.02
Gross Margin	-	14.95%	21.74%	23.33%	-
Operating Margin	-	-438.81%	-468.02%	-185.45%	-
Profit Margin	-	-438.81%	-468.02%	-185.24%	-
Free Cash Flow Margin	-	-318.79%	-316.24%	-87.95%	-
EBITDA	-	-0.42	-0.53	-0.2	-0.19
EBITDA Margin	-	-	-	-175.33%	-
D&A For EBITDA	-	0.01	0.01	0.01	0.02
EBIT	-0.47	-0.43	-0.54	-0.21	-0.21
EBIT Margin	-	-	-	-185.45%	-
Revenue as Reported	-	-	0.11	0.11	-

Source: S&P Capital IQ. Standard template. Financial Sources.